韩国患有合并症的儿科人群中的 COVID-19 疫苗接种状况。
COVID-19 Vaccination Status Among Korean Pediatric Population With Comorbidities.
机构信息
Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Information and Statistics, Department of Bio & Medical Big Data, Research Institute of Natural Science, Gyeongsang National University, Jinju, Korea.
出版信息
J Korean Med Sci. 2023 Aug 14;38(32):e248. doi: 10.3346/jkms.2023.38.e248.
The pediatric population with comorbidities is a high-risk group for severe coronavirus disease 2019 (COVID-19). As of January 2023, the COVID-19 vaccination rate for at least two doses among Korean children 5-11 years is low at 1.1%. We summarized the COVID-19 vaccination status for the pediatric population (5-17 years) with comorbidities through July 2022 using the National Health Insurance Service database. Pediatric patients with comorbidities had higher vaccination rates than the general pediatric population (2.4% vs. 1.1% in 5-11-year-olds [ < 0.001], 76.5% vs. 66.1% in 12-17-year-olds [ < 0.001]). However, there were substantial differences according to comorbidity category, and the 2-dose vaccination rate was lowest among children with immunodeficiency in all age groups (1.1% in 5-11-year-olds, 51.2% in 12-17-year-olds). The COVID-19 vaccination rate among Korean children has remained stagnant at a low proportion despite ongoing outreach. Thus, more proactive strategies are needed alongside continuous surveillance.
患有合并症的儿科人群是 2019 年冠状病毒病（COVID-19）重症的高危人群。截至 2023 年 1 月，韩国 5-11 岁儿童至少接种两剂 COVID-19 疫苗的比例较低，为 1.1%。我们使用国家健康保险服务数据库，总结了截至 2022 年 7 月患有合并症的儿科人群（5-17 岁）的 COVID-19 疫苗接种状况。患有合并症的儿科患者的疫苗接种率高于普通儿科人群（5-11 岁儿童中为 2.4%比 1.1%[ < 0.001]，12-17 岁儿童中为 76.5%比 66.1%[ < 0.001]）。然而，根据合并症类别存在显著差异，在所有年龄段中，免疫缺陷儿童的 2 剂疫苗接种率最低（5-11 岁儿童为 1.1%，12-17 岁儿童为 51.2%）。尽管持续开展宣传，但韩国儿童的 COVID-19 疫苗接种率仍停滞在低比例。因此，除了持续监测外，还需要采取更积极的策略。
Zotero 插件